Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOXANTRONE vs MOCLOBEMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITOXANTRONE vs MOCLOBEMIDE: Safety Overview

Metric MITOXANTRONE MOCLOBEMIDE
Total FAERS Reports 4,166 461
Deaths Reported 995 76
Death Rate 23.9% 16.5%
Hospitalizations 1,556 133
Average Patient Age 37.0 yrs 52.0 yrs
% Female Patients 48.0% 48.7%
FDA Approval Date Apr 11, 2006 N/A
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A